Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

LipidLaunch™ SM-102 LNP (human cGAS) is a solution containing lipid nanoparticles (LNPs) composed of the ionizable cationic aminolipid SM-102 (Item No. 33474), cholesterol (Item No. 9003100), 1,2-distearoyl-sn-glycero-3-PC (1,2-DSPC; Item No. 15100), and the lipid excipient DMG-PEG(2000) (Item No. 33945) at a molar ratio of 50:38.5:10:1.5 and encapsulating mRNA encoding His-tagged human cyclic GMP-AMP (cGAMP) synthase (cGAS), a nucleotidyltransferase involved in the innate immune response.1,2 It is intended for the overexpression of His-tagged human wild-type cGAS in vitro and can be used in a variety of model cell lines.
Suggested in vitro use: Thaw LNPs on ice with occasional gentle swirling (do not vortex). Using a gentle pipetting technique, dilute 1:100-1:500 in complete cell culture media (with serum) and add to subconfluent cells. Expression of His-tagged human cGAS may be detected between six and 48 hours after transfection. Optimal conditions are highly dependent on cell type.
WARNING This product is not for human or veterinary use.
1. Cyclic GMP-
2. Cyclic GMP-